Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | MEDP | HQY | ||
| Company | Charles River Laboratories Intl | Medpace Holdings Inc | Healthequity | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 181.54 | 334.68 | 93.21 | ||
| High | 188.04 | 342.50 | 95.58 | ||
| Low | 181.29 | 334.00 | 92.02 | ||
| Last | 185.77 | 337.28 | 94.95 | ||
| Change | +3.62 | +2.13 | +0.19 | ||
| % Change | +1.99% | +0.64% | +0.20% | ||
| Volume | 1,139,300 | 683,300 | 2,122,500 | ||
| 20-Day Average Volume | 552,810 | 276,030 | 898,010 | ||
| Previous Close | 182.15 | 335.15 | 94.76 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 194.21 | 342.09 | 98.63 | ||
| 20-Day Raw Stochastic | 24.40% | 31.81% | 29.78% | ||
| 20-Day Relative Strength | 44.04% | 48.22% | 49.42% | ||
| Weighted Alpha | -23.72 | -0.78 | +41.58 | ||
| Today's Opinion | 88% Sell | 72% Sell | 72% Buy | ||
| Previous Opinion | 88% Sell | 72% Sell | 72% Buy | ||
| Last Month's Opinion | 96% Sell | 96% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.46% since 12/13/24 | -2.50% since 12/13/24 | -0.70% since 12/13/24 | ||
| Low | 180.21 on 12/19/24 | 326.92 on 12/19/24 | 90.34 on 12/17/24 | ||
| High | 199.45 on 12/17/24 | 359.49 on 12/17/24 | 95.58 on 12/20/24 | ||
| 1-Month | |||||
| %Chg | -1.13% since 11/20/24 | +3.43% since 11/20/24 | -7.78% since 11/20/24 | ||
| Low | 180.21 on 12/19/24 | 324.55 on 11/21/24 | 90.34 on 12/17/24 | ||
| High | 203.01 on 12/02/24 | 359.49 on 12/17/24 | 105.82 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | -9.73% since 09/20/24 | -7.77% since 09/20/24 | +19.39% since 09/20/24 | ||
| Low | 176.48 on 10/31/24 | 302.01 on 10/22/24 | 76.85 on 10/03/24 | ||
| High | 230.02 on 11/06/24 | 370.31 on 11/08/24 | 105.82 on 11/25/24 | ||
| 6-Month | |||||
| %Chg | -11.38% since 06/20/24 | -15.81% since 06/20/24 | +15.43% since 06/20/24 | ||
| Low | 176.48 on 10/31/24 | 302.01 on 10/22/24 | 65.01 on 08/05/24 | ||
| High | 254.15 on 08/01/24 | 459.77 on 07/17/24 | 105.82 on 11/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,499,535 | 10,483,337 | 8,228,652 | ||
| Shares Outstanding, K | 51,136 | 31,082 | 86,663 | ||
| Annual Sales | 4,129,410,000 | 1,885,840,000 | 999,590,000 | ||
| Annual Net Income | 474,620,000 | 282,810,000 | 55,710,000 | ||
| Last Quarter Sales | 1,009,760,000 | 533,320,000 | 300,430,000 | ||
| Last Quarter Net Income | 69,280,000 | 96,430,000 | 5,700,000 | ||
| 60-Month Beta | 1.38 | 1.37 | 0.55 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.59 on 11/06/24 | 3.01 on 10/21/24 | 0.78 on 12/09/24 | ||
| Latest Earnings Date | 02/12/25 | 02/10/25 | 12/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.00 | 29.35 | 41.20 | ||